News
Important Only
Why Interactive Brokers Stock Slumped by 6% Today
Key PointsThe brokerage will be getting exactly $0 in revenue from a new service it's rolling out in Singapore.Although this follows a broad trend in the industry, investors clearly aren't happy about it.10 stocks we like better than Interactive Brokers Group › Investors didn't want to interact much...The Motley Fool
Wed, Aug 13
Ampco-Pittsburgh Reports Record Profit
Ampco-Pittsburgh(NYSE:AP) reported second-quarter 2025 results on Aug. 12, posting a net loss of $7.3 million (GAAP) due to a $6.8 million United Kingdom plant exit charge. Management announced progress winding down United Kingdom operations, strong adjusted EBITDA growth in the Air and Liquid Proce...The Motley Fool
Wed, Aug 13
Dolphin Entertainment Inc reports results for the quarter ended June 30 - Earnings Summary
Dolphin Entertainment Inc DLPN.OQ reported a quarterly adjusted loss of 5 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -16 cents. The lone analyst forecast for the quarter was for a loss of 5 cents per share. Revenue rose ...Reuters
Wed, Aug 13
Opus Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Opus Genetics Inc IRD.OQ reported a quarterly adjusted loss of 12 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -30 cents. The mean expectation of four analysts for the quarter was for a loss of 20 cents per share. Wall Str...Reuters
Wed, Aug 13
LiqTech International Lifts 2025 Outlook
LiqTech International (NASDAQ:LIQT) reported second-quarter 2025 results on Aug. 13, 2025, delivering almost $5 million in revenue. Revenue was up quarter over quarter, and management set a full-year revenue outlook of $19 million to $20 million, representing a 30%-37% year-over-year increase from 2...The Motley Fool
Wed, Aug 13
Vaxart Revenue Jumps 520% in Fiscal Q2
Key PointsVaxart’s GAAP revenue rose to $39.7 million in Q2 2025, over 18 times analyst estimates, mainly from government contract recognition tied to the COVID-19 trial.Research and development expense grew to $49.7 million (GAAP), compared to $17.5 million for the second quarter of 2024, reflectin...The Motley Fool
Wed, Aug 13
Vinci Partners AUM Hits $56 Billion
Vinci Partners Investments (NASDAQ:VINP) reported second quarter 2025 results on Aug. 12, 2025, with 65.2 million Brazilian reals (BRL) in fee-related earnings (non-GAAP), BRL75.8 million in adjusted distributable earnings, and a declared $0.15 per share dividend. The company highlighted double-digi...The Motley Fool
Wed, Aug 13
Allogene Narrows Loss in Fiscal Q2
Key PointsGAAP earnings per share improved to $(0.23) in Q2 2025Clinical trial timelines for key lymphoma and autoimmune disease programs were delayed by approximately two quarters.Cash and investments totaled $302.6 million at the end of Q2 2025, expected to support operations into the second half ...The Motley Fool
Wed, Aug 13
Why Curaleaf Stock Rocked the Market Today
Key PointsA congressman filed, for the fourth time in a row, a bill that would "reschedule" cannabis.This could be intended to prod President Trump into using his authority to effect the change.10 stocks we like better than Curaleaf › The halting, stop-and-go journey that is American marijuana legal...The Motley Fool
Wed, Aug 13
Why Dogecoin Is Soaring Today
Key PointsAnother major IPO kicked off today as shares of the crypto exchange Bullish began trading. Last week, President Trump gave his approval for cryptocurrencies to be included in retirement plans. Dogecoin is still a meme coin and should be treated by investors as a risky asset. 10 stocks we l...The Motley Fool
Wed, Aug 13
Kezar Narrows Loss 37 Percent in Q2
Key PointsGAAP net loss per share of $1.87 in Q2 2025 was narrower than expected and improved from the prior year.Research and development expenses declined compared to the same period in 2024. as clinical trial activity wound down.No revenue reported, but significant regulatory progress with zetomi...The Motley Fool
Wed, Aug 13
What's Behind Ether's (ETH) Latest Rally
Key PointsEther (ETH) climbed as much as 9.3% intraday and was up about 5.2% over 24 hours as of 2 p.m.The gains sprang from a mix of market forces and analyst reports.Ether has now gained about 72% over six months and about 973% over five years, highlighting both strong returns and high volatility....The Motley Fool
Wed, Aug 13
Barfresh Reports 11% Revenue Gain in Q2
Key Points- Revenue (GAAP) for Q2 2025 increased 11.0% year over year, but fell short of analyst estimates on a GAAP basis and prior guidance.- Gross margin declined to 31.1%, impacted by transition costs and early-stage production inefficiencies.- Fiscal 2025 revenue guidance was reduced to a range...The Motley Fool
Wed, Aug 13
Tenax Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Tenax Therapeutics Inc TENX.OQ reported a quarterly adjusted loss of 27 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.83. The mean expectation of four analysts for the quarter was for a loss of 24 cents per share. Wall ...Reuters
Wed, Aug 13
Enliven Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Enliven Therapeutics Inc ELVN.OQ reported a quarterly adjusted loss of 49 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -41 cents. The mean expectation of nine analysts for the quarter was for a loss of 53 cents per share. W...Reuters
Wed, Aug 13
Lumentum Q4 Revenue and Margins Surge
Lumentum(NASDAQ:LITE) reported fourth quarter fiscal 2025 results on August 12, 2025, with non-GAAP revenue of $480.7 million and non-GAAP EPS of $0.88, both exceeding the high end of guidance. The company’s non-GAAP gross margin rose to 37.8%, up 260 basis points quarter-over-quarter and 1,000 basi...The Motley Fool
Wed, Aug 13
Kezar Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
Kezar Life Sciences Inc KZR.OQ reported a quarterly adjusted loss of $1.87 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.70. The mean expectation of six analysts for the quarter was for a loss of $2.39 per share. Wall Street ...Reuters
Wed, Aug 13
Why Tencent Rallied Today
Key PointsTencent delivered strong Q2 results. Revenue accelerated and grew double-digits across most business segments. Artificial intelligence and a recovering Chinese economy are helping lift results. 10 stocks we like better than Tencent › Shares of Chinese tech giant Tencent (OTC: TCEHY) rallie...The Motley Fool
Wed, Aug 13
Inhibrx Biosciences Beats Earnings
Key PointsGAAP earnings per share of $(1.85) for Q2 2025 beat expectations by $0.91, reflecting much narrower losses than forecasted, with GAAP EPS of $(1.85) versus the analyst estimate of $(2.76).GAAP revenue reached $1.3 million for Q2 2025, exceeding the consensus estimate by $1.3 million.These ...The Motley Fool
Wed, Aug 13
Borr Drilling Ltd reports results for the quarter ended June 30 - Earnings Summary
Borr Drilling Ltd BORR.N reported quarterly adjusted earnings of 14 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 12 cents. The mean expectation of four analysts for the quarter was for earnings of 10 cents per share. Wall ...Reuters
Wed, Aug 13
